MyHealthChecked PLC Result of General Meeting (7836I)
06 December 2022 - 11:23PM
UK Regulatory
TIDMMHC
RNS Number : 7836I
MyHealthChecked PLC
06 December 2022
MyHealthChecked PLC
( " MyHealthChecked " or the "Company " )
Result of General Meeting
MyHealthChecked PLC (AIM: MHC), the consumer home-testing
healthcare company, announces that at the General Meeting held
earlier today, all resolutions were duly passed.
Resolution Votes for(1) % of shares Votes against(3) % of shares
(all are special resolutions) voted(2) voted
Resolution 1 99,254,512 99.65% 350,867 0.35%
------------- ------------ ----------------- ------------
Resolution 2 99,229,512 99.65% 360,867 0.35%
------------- ------------ ----------------- ------------
Resolution 3 98,833,632 99.23% 771,747 0.77%
------------- ------------ ----------------- ------------
Notes :
(1) Any proxy appointments which gave discretion to the Chairman
have been included in the "for" total.
(2) As a percentage of the aggregate of votes "for" plus votes
"against".
(3) An abstention is not counted towards the votes cast "for" or
"against" a resolution.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com
Penny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)20 3179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44
(0)7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests that have been developed following the acquisition of
The Genome Store in November 2020. The tests are available online,
and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROMFLFFFFFLRIIF
(END) Dow Jones Newswires
December 06, 2022 07:23 ET (12:23 GMT)
MyHealthChecked (AQSE:MHC.GB)
Historical Stock Chart
From Aug 2024 to Sep 2024
MyHealthChecked (AQSE:MHC.GB)
Historical Stock Chart
From Sep 2023 to Sep 2024